Getting RNA-Seq Right and Getting it Fast with GPU-Accelerated Computing

RNA-Seq analysis often seems straightforward, like just pushing a button. But to do it well, especially for finding new drugs, you need more than just a basic approach. Every study, every experiment, and every set of data is unique. Getting RNA-Seq analysis right means you need to understand biology, be good with statistics, and really dig into the data. 

Here’s where pre-canned workflows can fall short:

Alignment and Quantification: It Starts with How You Prepare the Samples

Best practices for alignment and quantification include tools like STAR for alignment and Salmon or Kallisto for counting, or for even faster analyses, GPU-accelerated NVIDIA Parabricks. Check your assumptions before designing an analysis to avoid pitfalls.

• Unusual Samples: If you’re working with special models, like those from patient tumors (PDX), a standard method might incorrectly match human reads to mouse DNA and vice-versa. An expert knows to set up a two-step alignment before starting to keep these reads separate.
• Knowing Your Library: Did the lab use a strand-specific library? Failing to choose the right settings in your analysis means your counts will be flipped, and your results misleading.
• New Biology Needs Adjustments: In drug discovery, we often look at unusual genomic variations or organisms that aren’t well-studied. Default settings in an alignment tool can miss widespread RNA editing events, or large changes in tumor DNA. Genomic differences in an unusual model organism can be filtered out as “low quality” without custom STAR settings like outFilterMismatchNoverLmax.

Speed matters

Knowing which tool to use for the job is critical. The GPU-enabled Parabricks¹ rna_fq2bam (GPU-accelerated STAR), finishes in minutes alignments that used to take hours, allowing users to quickly iterate over an analysis to find the optimum parameters. With a fast test-loop like this, analysts can do the job properly—testing different settings, checking the results against a known standard, and iterating until the results capture the real biology. This is simply impossible with a multi-hour analysis. Then, once the parameters are optimized, these tools will perform faster and cheaper for pipelines that need to operate at scale. Anecdotally, at Diamond Age, we’ve found using GPU based tools can reduce the runtime of resource heavy tasks from 10 hours to 15 minutes, a benefit appreciated by our consultants and clients alike.

It’s not just standard alignment that can be sped up. GPU accelerated tools especially shine for the more complex and long-running alignment-based tools. For example, DeepSAP² not only accelerates splice junction detection but also improves accuracy, achieving an F1 score of 0.971 compared with 0.821 for STAR. Its transformer‑based splice scoring module can also be integrated with STAR to further enhance performance.

In drug discovery, where you’re often looking for subtle splicing changes that difference between 0.82 and 0.97 is the difference between finding real signals and chasing false positives.

This doesn’t mean you can just run these tools and trust every fusion or splice junction, but it does mean that you’ll be working with higher quality results that haven’t already thrown away important biological signals. So while you can run your data through tools like Parabricks and get results quickly, whether those results are meaningful depends entirely on whether someone with expertise set up the analysis correctly, evaluate quality metrics properly, and understood what the numbers actually mean for specific biological questions. GPU acceleration is a powerful tool—and like any tool, it’s only as effective as the expertise guiding its use.